ClinicalTrials.gg
CompletedNCT07760701MCEUpdated Aug 12, 2026

Description of the Lived Experiences of Family Caregivers for People With Mental Health Comorbidities

An observational study in Depression, Anxiety and Trauma, sponsored by Centre for Infectious Disease Research in Zambia. Completed at 1 site in Zambia. Per ClinicalTrials.gov, last updated 2026-08-12.

Sponsored by Centre for Infectious Disease Research in Zambia · Observational

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
30
Sex
All
01

Study summary

Mental health problems such as depression, trauma and anxiety are common in low-resource contexts, such as Zambia. Comorbidity, or having multiple mental health problems, is the norm. Family or friends often care for these individuals in the home. Providing care often leads to disrupted social life, financial hardships and emotional stress. Extant research shows mental health concerns were exacerbated by COVID-19, however, very little is known about the experiences of family caregivers in Zambia during the COVID-19 pandemic. This project aims to describe the lived experiences of family caregivers, including challenges, self-directed coping skills, and access to services and resources.

Read the detailed description

Mental health problems such as depression, anxiety, trauma, substance and alcohol use are common and a primary driver of disease burden globally. In Zambia, the prevalence of mental health problems is an estimated 20%. Mental health comorbidity, which is the occurrence of multiple mental health problems at the same time, is more common among impoverished communities. Over 60% of Zambians are classified as poor, a population particularly at-risk for the most severe and lifelong mental health conditions. Common risk factors for mental health comorbidities include domestic violence and stress, grief and loss, infections such as malaria, HIV and syphilis, and poverty which limits access to care and basic needs such as clean water, electricity and proper housing.

Individuals with mental health comorbidities in low resource settings are often cared for by family caregivers. Family caregivers opt to care for their relatives from home due to the stigma associated with having a relative hospitalized in a mental health facility. Further, limited healthcare resources and knowledge of mental health comorbidities make home-based care more accessible. While caring for an individual with mental health comorbidities can be a positive and rewarding experience, it can also lead to the caregiver experiencing disruptions in their social life, increased financial costs, reduced self-care, and other adverse emotional responses such as self-blame, burnout, anxiety and sadness. The COVID-19 pandemic has worsened the severity and frequency of mental health comorbidities, increasing burden and psychological reactions among caregivers, and in turn, impacting their ability to provide care. In addition, existing evidence suggests these psychological reactions impact adherence to public health measures that reduce risk of infection, sickness and death. Few studies have explored the perspectives of recipients of caregiver-provided mental health care, caregivers, and mental health experts on how best to care for individuals with pre-existing mental health comorbidities during the pandemic. Together, these key perspectives can provide deeper insights on how to increase access to services and resources for caregivers, coping skills, and inform future development of policy guidelines.

Aim This project aims to describe the lived experiences of family caregivers, including challenges, self-directed coping skills, and access to services and resources.

Research questions

  1. What are the experiences of family caregivers providing care for individuals with mental health comorbidities in low resource contexts during the COVID-19 pandemic?
  2. What resources are available to support family caregivers to enhance home-based care for individuals with mental health comorbidities?
  3. What are the recommendations from caregivers, recipients of care and mental health experts when caring for individuals with mental health comorbidities in low resource contexts during the COVID-19 pandemic?
02

Conditions studied

  • Depression
  • Anxiety
  • Trauma

Keywords

  • family caregivers
  • mental health comorbidity
  • Covid-19
03

In context

Depression

8,582 studies on the registry are indexed under Depression; 1,723 are open to participants now.

This study's enrollment of 30 is below the median of 175 across 1,259 observational studies indexed under Depression.

Browse Depression studies →

Lead sponsor

Centre for Infectious Disease Research in Zambia is the lead sponsor of 41 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The population for this study will be comprised of 1) caregivers that have provided unpaid mental health care to a relative with mental health comorbidities during the pandemic, 2) individuals aged 15 and above with mental health comorbidities that have received care from family caregivers during the pandemic, and 3) mental health experts that provide professional care for mental health comorbidities

Eligibility criteria

  1. Mental health experts Inclusion criteria

    1. Provided counselling or psychiatric care to care-recipients during the COVID-19 pandemic
    2. Works within or around Lusaka city
    3. Willing to participate in the study Exclusion criteria

    a. Did not interact with family caregivers extensively

  2. Family caregivers Inclusion criteria

    1. Provide unpaid care to a care-recipient during the COVID-19 pandemic
    2. Live in the same house with the care-recipient Exclusion criteria

    <!-- -->

    1. Unrelated to care-recipient. Other carer's such as housekeepers that may assist with home-based care for care-recipients.
    2. Other relatives that assist with logistics (for example driving the patient to a hospital) but do not spend significant time with the patient.
  3. Care-recipients Inclusion criteria

    1. Experience one or more mental health problems as reported by either the caregiver or themselves
    2. Cared for by a family caregiver in a home setting during the COVID-19 pandemic
    3. Aged 15 years and above Exclusion criteria

    <!-- -->

    1. Care-recipient's with severe mental health illness (e.g. psychosis, schizophrenia and severe dementia) that prevents them from giving .
    2. Care-recipients institutionalized in a mental health facility and not receiving care from a family caregiver during the COVID-19 pandemic
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
30 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Identification of meaning units

    Determine caregiver experiences that are meaningful using semi-structured interview guides

    Time frame: Single time point

07

Study locations

1 site
  • CIDRZ
    Lusaka, Lusaka Province 10101, Zambia
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jul 2023 to primary completion in May 2024, 10 months.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 17, 2025
First posted
Aug 12, 2026
StartActual
Jul 15, 2023
Primary completionActual
May 29, 2024
CompletionActual
May 29, 2024
Last update
Aug 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07760701
Lead sponsor
Centre for Infectious Disease Research in Zambia
Responsible party
Sponsor
First posted
Aug 12, 2026
Start date
Jul 15, 2023
Primary completion
May 29, 2024
Completion
May 29, 2024
Last update
Aug 12, 2026

Study contacts

Mwamba Mwila Mwenge, MBA, MSc
principal investigator · Centre for Infectious Disease Research in Zambia
Mwamba Mwenge, MBA, MSc
principal investigator · Centre for Infectious Disease Research in Zambia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion